CAS 1346607-05-3

6-Chloro-5-(2'-hydroxy-3'-methoxy-[1,1'-biphenyl]-4-yl)-3-(3-methoxyphenyl)-1H-pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione

CAS : 1346607-05-3

Formule : C₂₆H₂₀ClN₃O₅

Degré de pureté : %

Couleur et forme : Solid

Masse moléculaire : 489.9071

Ref: IN-DA01ENTP

Gsk621

CAS : 1346607-05-3

Gsk621

Formule : C₂₆H₂₀ClN₃O₅

Degré de pureté : 98+%

Masse moléculaire : 489.91

Ref: 54-OR1024378

GSK621

CAS : 1346607-05-3

GSK621

Formule : C₂₆H₂₀ClN₃O₅

Degré de pureté : ≥95%

Masse moléculaire : 489.91

Ref: 54-BUP03201

GSK621

CAS : 1346607-05-3

GSK621 is a specific and potent AMPK activator.

Formule : C₂₆H₂₀ClN₃O₅

Degré de pureté : 97.02% - 97.05%

Couleur et forme : Solid

Masse moléculaire : 489.91

Ref: TM-T6854

GSK621

CAS : 1346607-05-3

6-Chloro-5-(2'-hydroxy-3'-methoxy-[1,1'-biphenyl]-4-yl)-3-(3-methoxyphenyl)-1H-pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione

Formule : C₂₆H₂₀ClN₃O₅

Degré de pureté : 98+%

Masse moléculaire : 489.91

Ref: IN-DG764852

GSK621

CAS : 1346607-05-3

GSK621 is a selective inhibitor, which is synthesized for research purposes in the modulation of enzymatic activity. This compound is sourced through synthetic chemical processes and designed to selectively target the phosphoinositide 3-kinase (PI3K) pathway. GSK621's mode of action involves the inhibition of the PI3K pathway, a critical signaling pathway involved in cellular functions such as growth, proliferation, and survival. By inhibiting this pathway, GSK621 can modulate aberrant signaling commonly observed in various cancers.

Formule : C₂₆H₂₀ClN₃O₅

Degré de pureté : Min. 95%

Masse moléculaire : 489.91 g/mol

Ref: 3D-WDC60705